124 related articles for article (PubMed ID: 16135562)
1. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells.
Lugo-Villarino G; Ito S; Klinman DM; Glimcher LH
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13248-53. PubMed ID: 16135562
[TBL] [Abstract][Full Text] [Related]
2. CpG-activated Thy1.2+ dendritic cells protect against lethal Listeria monocytogenes infection.
Ishii KJ; Ito S; Tamura T; Hemmi H; Conover J; Ozato K; Akira S; Klinman DM
Eur J Immunol; 2005 Aug; 35(8):2397-405. PubMed ID: 16047338
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells.
Wang J; Fathman JW; Lugo-Villarino G; Scimone L; von Andrian U; Dorfman DM; Glimcher LH
J Clin Invest; 2006 Feb; 116(2):414-21. PubMed ID: 16410834
[TBL] [Abstract][Full Text] [Related]
4. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice.
Shah JA; Darrah PA; Ambrozak DR; Turon TN; Mendez S; Kirman J; Wu CY; Glaichenhaus N; Seder RA
J Exp Med; 2003 Jul; 198(2):281-91. PubMed ID: 12874261
[TBL] [Abstract][Full Text] [Related]
6. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
7. CpG ODN nanorings induce IFNα from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity.
Gungor B; Yagci FC; Tincer G; Bayyurt B; Alpdundar E; Yildiz S; Ozcan M; Gursel I; Gursel M
Sci Transl Med; 2014 May; 6(235):235ra61. PubMed ID: 24807558
[TBL] [Abstract][Full Text] [Related]
8. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
9. Effects of CpG-oligodeoxynucleotides on dendritic cell development.
Ohue R; Tani F; Kitabatake N
Nucleic Acids Symp Ser (Oxf); 2008; (52):647-8. PubMed ID: 18776546
[TBL] [Abstract][Full Text] [Related]
10. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
Agallou M; Margaroni M; Karagouni E
Vaccine; 2011 Jul; 29(31):5053-64. PubMed ID: 21569815
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides.
Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA
Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection.
Donhauser N; Helm M; Pritschet K; Schuster P; Ries M; Korn K; Vollmer J; Schmidt B
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):161-71. PubMed ID: 20156099
[TBL] [Abstract][Full Text] [Related]
13. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
Gray RC; Kuchtey J; Harding CV
J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production.
Malarkey CS; Gustafson CE; Saifee JF; Torres RM; Churchill ME; Janoff EN
PLoS One; 2016; 11(6):e0157157. PubMed ID: 27280778
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope.
Cornet S; Menez-Jamet J; Lemonnier F; Kosmatopoulos K; Miconnet I
Vaccine; 2006 Mar; 24(11):1880-8. PubMed ID: 16300869
[TBL] [Abstract][Full Text] [Related]
16. Effects of CpG oligodeoxynucleotide on transcription factors GATA-3 and T-bet mRNA expression in asthmatic mice.
Wu ZQ; Xu YP; Xiang H; Shen HH
Acta Pharmacol Sin; 2005 Sep; 26(9):1117-22. PubMed ID: 16115380
[TBL] [Abstract][Full Text] [Related]
17. CpG oligonucleotides induce the differentiation of CD4(+)Th17 cells by triggering plasmacytoid dendritic cells in adoptively cell transfer immunotherapy.
Xu L; Wang C; Zhou Y; Ren T; Wen Z
Immunol Lett; 2012 Feb; 142(1-2):55-63. PubMed ID: 22249078
[TBL] [Abstract][Full Text] [Related]
18. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
[TBL] [Abstract][Full Text] [Related]
20. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
